WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 5'2201 Infant (under 12 months) mortality rate: 142
GDP / capita (US$): 8'8901 Child (under 5 years) mortality rate: 172

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 2'784  2'769  2'755  2'741  2'730  2'582  2'365  2'132 
Births 50  50  51  51  51  57  61  62 
Surviving infants 49  49  49  50  50  55  59  60 
Pop. less than 5 years 249  254  254  246  245  283  290  283 
Pop. less than 15 years 756  773  787  796  807  843  831  858 
Female 15-49 years 738  732  726  722  718  673  594  484 

Number of reported case

(Click for retrospective incidence data for Jamaica)
Diphtheria 13 
Japanese encephalitis
Measles 3'651  36 
Mumps 10 
Pertussis 23  13 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 10 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Jamaica)
Vaccine year result method % card seen                                                
BCG 2009  100  MICS   78  93  96  99*  95  94  93  98  38 
DTP1 2009  98  MICS   78  92  95  94  92  91  87 
DTP3 2009  92  MICS   78  93  96  92  94  90  86  86  24 
HepB_BD         
HepB3 2009  92  MICS   78  93  96  92  94  90 
Hib3 2009  92  MICS   78  93  96  91  94  90 
JapEnc         
MCV 2009  94  MICS   78  94  93  88  89  88  88  74 
MCV2          71  76  60  57  79 
PCV1          99*  14 
PCV3          70  17 
Pol3 2009  92  MICS   78  86  96  93  94  90  86  87  34 
Rota1         
Rota_last         
Rubella1          94  93  88  89  88 
TT2plus 2009  26  MICS   78  32  59  67  63  53  55 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Jamaica)
BCG 93  95  95  95  94  94  98  38 
DTP1 97  98  94  98  91  97  95  48 
DTP3 93  96  92  94  90  93  86  24 
HepB3 93  96  92  94  90 
HepB_BD
Hib3 93  96  91  94  90 
MCV 94  93  88  89  88  88  74 
MCV2 71  76  60  56  78 
PAB 80  80  80  80  62  51 
PnC3
Pol3 86  96  93  94  90  95  87  34 
Rota_last

Number of districts in the country 13  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 77
From 80 to 89% 23
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 6 weeks; 3, 5-6, 18 months; 4-6 years; Yes Pertussis contrindication
DTwP 18 months; 4-6 years; Yes
DTwPHibHep 6 weeks; 3, 5-6 months; Yes
HIB 6 weeks; 3, 5-6 months; Yes pertussis contrindication
HepB 6 weeks; 3, 5-6 months Yes or 1st contact, +1, +6 months (for at risk persons)
IPV 6 weeks; 3, 5-6, 18 months; 4-6 years; Yes immunocompromised
Influenza Yes Health workers & children with chronic diseases
MMR 12-23 months; 4-6 years; Yes
OPV 6 weeks; 3, 5-6, 18 months; 4-6 years; Yes
Pneumo_conj 2, 4, 6, 18 months; Yes Children with sickle cell disease and HIV infected
Td 4-6 years; Yes PW and adults
YF Yes travelers to endemic countries

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  No  No  No  No 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number 13  13  13  13  13  13  13 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No       

System performance

Total Nº districts in country number 13  13  13  13  13  13  13 
Nº districts with DTP3 coverage >=80% number 13  12  11  11  13 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  92  85  85  100  69  69 
Nº districts with measles (MCV1) coverage >=95% number  
% of districts with MCV1 coverage >=95% From 0 to 100% 54  69  15  31   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  100    100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.